Search

everythinglearnresearchcommunity

for

Search:↓

High levels of the protein Flightless I worsen ulcerative colitis symptoms in mice.

CTA is often mistaken for AA but doesn't respond to steroids and may require hair transplantation.

Dupilumab for skin problems might reactivate hair loss in some patients.

Stopping JAK inhibitor treatment for hair loss can lead to worse hair loss than before the treatment.

NDP-MSH protects brain cells and reduces inflammation in Parkinson's disease by activating MC1R and involving Tregs.

Children with autoimmune gastritis showed improved intestinal health over time and should be checked for other autoimmune conditions.

A medication may help with hair growth in psoriasis, and a skin condition might be linked to a specific bacteria.

Ginsenoside Rg1 protects mouse skin from UVB damage and helps control inflammation.

Ustekinumab might work for severe psoriasis, but more research is needed to be sure.

Early intervention with JAK inhibitors may prevent alopecia areata progression.

Some skin diseases may indicate a higher risk of metabolic syndrome and related health issues.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

ILC1 cells contribute to hair loss in alopecia areata.

CBD can either promote or inhibit hair growth depending on the concentration used.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Two patients with psoriasis grew extra hair after using certain psoriasis medications.

Glycemic control medications for Type 2 diabetes can affect skin conditions like psoriasis.

Higher CRBP1 levels are linked to more severe alopecia areata.

TNF-alpha inhibitors can cause various immune-related skin issues.

Belimumab effectively controls SLE disease activity and reduces steroid use.

Early diagnosis and aggressive treatment are crucial for Cicatricial Alopecia, and treatment effectiveness varies among patients.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

Contact immunotherapy can cause vitiligo in patients with autoimmune conditions.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

Janus kinase inhibitors show promise in treating autoimmune skin diseases.

Leflunomide is more likely to help treat alopecia areata than cause it.

A young child with alopecia areata and psoriasis improved with treatment, suggesting a link between the two conditions.

Oleoylethanolamide (OEA) safely boosts fat production in skin cells and may help treat dry skin and reduce inflammation.

Oral vitamin D treatment can help some children with alopecia areata who have vitamin D deficiency.